Shareholders Equity: The sum of preferred and common equity items.
Adial Pharmaceuticals, Inc. (ADIL) had Shareholders Equity of $4.07M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-13.20M |
|
-- |
|
-- |
|
$8.28M |
|
$-8.28M |
|
$-4.91M |
|
$-13.20M |
|
$-13.20M |
|
$-13.20M |
|
$-13.20M |
|
$-13.20M |
|
$-13.20M |
|
$-8.28M |
|
$-8.28M |
|
4.85M |
|
4.85M |
|
$-2.72 |
|
$-2.72 |
|
| Balance Sheet Financials | |
$4.06M |
|
-- |
|
$0.99M |
|
$5.04M |
|
$0.98M |
|
-- |
|
-- |
|
$0.98M |
|
$4.07M |
|
$4.06M |
|
|
Shareholders Equity |
$4.07M |
6.47M |
|
| Cash Flow Statement Financials | |
$-6.92M |
|
-- |
|
$7.85M |
|
$2.83M |
|
$3.75M |
|
$0.92M |
|
$0.80M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.16 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-6.92M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-324.42% |
|
-324.68% |
|
-261.65% |
|
-324.41% |
|
$0.63 |
|
$-1.43 |
|
$-1.43 |
|